Back to Report Store Home

Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies

  • Published: Sep-2013
  • Report Code: GBIHC303MR
  • Report Format: pdf

Description

List of Figures

List of Figures

Figure 1: Solid Tumors Market, Asia-Pacific, Bladder Cancer, Epidemiology, 2012–2019

Figure 2: Solid Tumors Market, Bladder Cancer, Treatment Algorithm, Superficial and Stage I, 2013

Figure 3: Solid Tumors Market, Bladder Cancer, Treatment Algorithm, Stage II and III, 2013

Figure 4: Solid Tumors Market, Asia-Pacific, Ovarian Cancer, Epidemiology, 2012–2019

Figure 5: Solid Tumors Market, Ovarian Cancer, Treatment Algorithm, Stage I and II, 2013

Figure 6: Solid Tumors Market, Ovarian Cancer, Treatment Algorithm, Stage III and IV, 2013

Figure 7: Solid Tumors Market, Asia-Pacific, Pancreatic Cancer, Epidemiology, 2012–2019

Figure 8: Solid Tumors Market, Pancreatic Cancer, Treatment Algorithm, 2013

Figure 9: Solid Tumors Market, Asia-Pacific, Prostate Cancer, Epidemiology, 2012–2019

Figure 10: Solid Tumors Market, Prostate Cancer, Treatment Algorithm, 2013

Figure 11: Solid Tumors Market, Global, Avastin, Annual Sales ($m), 2006–2013e

Figure 12: Solid Tumors Market, Global, Tarceva, Annual Sales ($m), 2006–2013e

Figure 13: Solid Tumors Market, Global, Sutent, Annual Sales ($m), 2006–2013e

Figure 14: Solid Tumors Market, Global, Afinitor, Annual Sales ($m), 2009–2013e

Figure 15: Solid Tumors Market, Global, Zytiga, Annual Sales ($m), 2011–2013e

Figure 16: Solid Tumors Market, Global, Jevtana, Annual Sales ($m), 2010–2013e

Figure 17: Solid Tumors Market, Global, Bladder Cancer, Pipeline, 2013

Figure 18: Solid Tumors Market, Global, Bladder Cancer, Pipeline by Molecule Type, 2013

Figure 19: Solid Tumors Market, Global, Bladder Cancer, Pipeline by Mechanism of Action, 2013

Figure 20: Solid Tumors Market, Global, Ovarian Cancer, Pipeline, 2013

Figure 21: Solid Tumors Market, Global, Ovarian Cancer, Pipeline by Molecule Type, 2013

Figure 22: Solid Tumors Market, Global, Ovarian Cancer, Pipeline by Mechanism of Action, 2013

Figure 23: Solid Tumors Market, Global, Pancreatic Cancer, Pipeline, 2013

Figure 24: Solid Tumors Market, Global, Pancreatic Cancer, Pipeline by Molecule Type, 2013

Figure 25: Solid Tumors Market, Global, Pancreatic Cancer, Pipeline by Mechanism of Action, 2013

Figure 26: Solid Tumors Market, Global, Prostate Cancer, Pipeline, 2013

Figure 27: Solid Tumors Market, Global, Prostate Cancer, Pipeline by Molecule Type, 2013

Figure 28: Solid Tumors Market, Global, Prostate Cancer, Pipeline by Mechanism of Action, 2013

Figure 29: Solid Tumors Market, Asia-Pacific, Market Size ($m), 2012–2019

Figure 30: Solid Tumors Market, India, Market Size ($m), 2012–2019

Figure 31: Solid Tumors Market, Australia, Market Size ($m), 2012–2019

Figure 32: Solid Tumors Market, China, Market Size ($m), 2012–2019

Figure 33: Solid Tumors Market, Japan, Market Size ($m), 2012–2019

Figure 34: Solid Tumors Market, Global, Deals, 2006–2013

Figure 35: Solid Tumors Market, Global, Co-development Deals, 2006–2013

Figure 36: Solid Tumors Market, Global, Licensing Deals, 2006-2013

Figure 37: GBI Research Market Forecasting Model

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards